Logan Lester, DPT in Jefferson, IA - Physical Medicine & Rehabilitation

Logan Lester, DPT is a Physical Medicine & Rehabilitation physician based in Jefferson, Iowa. Logan Lester is licensed to practice in Iowa (license number 111231) and her current practice location is 1000 W Lincoln Way, Jefferson, Iowa. She can be reached at her office (for appointments etc.) via phone at (515) 386-4284.

NPI number for Logan Lester is 1710769393 and her current mailing address is Po Box 461, Nevada, Iowa. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1710769393.

Contact Information

	Logan Lester, DPT
	1000 W Lincoln Way, Jefferson, IA 50129-1645
	(515) 386-4284
	Not Available

Physician's Profile

Full Name	Logan Lester
Gender	Female
Speciality	Physical Medicine & Rehabilitation
Location	1000 W Lincoln Way, Jefferson, Iowa
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1710769393
Provider Enumeration Date: 10/18/2023
Last Update Date: 10/18/2023

Medical Identifiers

Medical identifiers for Logan Lester such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1710769393	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208100000X	Physical Medicine & Rehabilitation	111231 (Iowa)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Logan Lester is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Logan Lester, DPT Po Box 461, Nevada, IA 50201-0461 Ph: (515) 382-3366	Logan Lester, DPT 1000 W Lincoln Way, Jefferson, IA 50129-1645 Ph: (515) 386-4284

News Archive

Study: Century-old drug may help treat autism

Autism spectrum disorders (ASD) affect 1 to 2 percent of children in the United States. Hundreds of genetic and environmental factors have been shown to increase the risk of ASD. Researchers at UC San Diego School of Medicine previously reported that a drug used for almost a century to treat trypanosomiasis, or sleeping sickness, reversed environmental autism-like symptoms in mice.

Emergency room providers need to ask suicidal patients about access to firearms: Study

Although guns are used in over half of all American suicides, a new study shows that many emergency room doctors and nurses do not routinely ask suicidal patients about their access to firearms.

Study shows patients regain hand function when given cortical stimulation with rehab

Sending tiny electric pulses to a part of the brain controlling motor function helps ischemic stroke survivors regain partial use of a weakened hand, new Oregon Health & Science University research shows.

PharmaEngine presents PEP02 phase II studies in gastric and pancreatic cancers at ASCO 2011

PharmaEngine, Inc. announced today that two phase II studies of PEP02 (liposome irinotecan) in gastric and pancreatic cancer studies were presented at the 2011 Gastrointestinal Cancers Symposium of the American Society of Clinical Oncology (ASCO) in San Francisco, CA, USA.

Logan Lester, DPT - Physical Medicine & Rehabilitation in Jefferson, IA